Literature DB >> 1601852

Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity.

H L Schwartz1, K A Strait, N C Ling, J H Oppenheimer.   

Abstract

A panel of anti-thyroid hormone receptor (TR) antisera were generated to allow direct assay of the concentrations of the alpha 1 and beta 1 receptor isoforms in nuclear extracts from adult rat liver, kidney, brain and heart, and fetal brain. An antiserum, immunoglobulin G (IgG)-beta 1, raised against amino acid sequence 62-92 of the rat TR-beta 1 specifically precipitated only TR-beta 1 in vitro translation products. A second antiserum, IgG-alpha 1/beta, generated against a sequence that is identical in the ligand binding region of rat TR-alpha 1 and TR-beta isoforms immunoprecipitated both TR-alpha 1 and -beta 1 translation products. These IgG preparations were used to specifically immunoprecipitate thyroid hormone receptor binding activity from nuclear extracts. IgG-beta 1 cleared almost 80%, and the IgG-alpha 1/beta immunoprecipitated nearly all binding from hepatic nuclear extracts. This distribution of TR protein, 80% beta 1 and 20% alpha 1, is the same as previously reported for their respective mRNAs in liver. In heart, kidney, and brain IgG-beta 1 cleared 45, 43, and 28% of total binding, respectively, and IgG-alpha 1/beta cleared all T3 binding activity from these tissues. In agreement with an earlier study, marked variations in specific protein/mRNA ratios were noted among these tissues. Consistent with our earlier report of the presence of only very low levels of TR-beta 1 mRNA in fetal brain, IgG-beta 1 cleared just 5% of binding in this tissue. Studies using an antiserum (IgG-ch) generated against homologous segments of the hinge region in both TR-alpha 1 and -beta 1 yielded results which contrasted sharply with those of IgG-alpha 1/beta. Whereas IgG-ch could also immunoprecipitate virtually all binding from hepatic extracts it cleared only 40-50% of binding from the other tissues, including fetal brain in which TR-alpha 1 accounts for greater than 90% of binding protein. The data suggest the presence of posttranslational modification of the TR-alpha 1 protein in the hinge region, consistent with the presence in this segment of potential phosphorylation sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601852

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Tissue-specific actions of thyroid hormone: insights from animal models.

Authors:  G A Brent
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor.

Authors:  Hao Ying; Osamu Araki; Fumihiko Furuya; Yasuhito Kato; Sheue-Yann Cheng
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

Review 3.  Physiological consequences of the TRalpha1 aporeceptor state.

Authors:  Jens Mittag; Karin Wallis; Björn Vennström
Journal:  Heart Fail Rev       Date:  2008-11-14       Impact factor: 4.214

4.  A Purkinje cell protein-2 intronic thyroid hormone response element binds developmentally regulated thyroid hormone receptor-nuclear protein complexes.

Authors:  S G Hagen; R J Larson; K A Strait; J H Oppenheimer
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

Review 5.  Nuclear receptors in neural stem/progenitor cell homeostasis.

Authors:  Dimitrios Gkikas; Matina Tsampoula; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2017-06-21       Impact factor: 9.261

6.  Identification of a new hormone-binding site on the surface of thyroid hormone receptor.

Authors:  P C T Souza; A C Puhl; L Martínez; R Aparício; A S Nascimento; A C M Figueira; P Nguyen; P Webb; M S Skaf; I Polikarpov
Journal:  Mol Endocrinol       Date:  2014-02-19

7.  Naturally Occurring Amino Acids in Helix 10 of the Thyroid Hormone Receptor Mediate Isoform-Specific TH Gene Regulation.

Authors:  Vitor M S Pinto; Svetlana Minakhina; Shuiqing Qiu; Aniket Sidhaye; Michael P Brotherton; Amy Suhotliv; Fredric E Wondisford
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

8.  Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.

Authors:  Lisen Johansson; Mats Rudling; Thomas S Scanlan; Thomas Lundåsen; Paul Webb; John Baxter; Bo Angelin; Paolo Parini
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

9.  A TRbeta-selective agonist confers resistance to diet-induced obesity.

Authors:  Beatriz S Amorim; Cintia B Ueta; Beatriz C G Freitas; Renata J Nassif; Cecília Helena de Azevedo Gouveia; Marcelo A Christoffolete; Anselmo S Moriscot; Carmen Lucia Lancelloti; Flávia Llimona; Hermes Vieira Barbeiro; Heraldo Possolo de Souza; Sergio Catanozi; Marisa Passarelli; Marcelo S Aoki; Antonio C Bianco; Miriam O Ribeiro
Journal:  J Endocrinol       Date:  2009-08-27       Impact factor: 4.286

10.  Mice lacking thyroid hormone receptor Beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy.

Authors:  Raquel López-Fontal; Miriam Zeini; Paqui G Través; Mariana Gómez-Ferrería; Ana Aranda; Guillermo T Sáez; Concha Cerdá; Paloma Martín-Sanz; Sonsoles Hortelano; Lisardo Boscá
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.